Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mackay

Showing results (571-580 of 630) with videos related to

Pageof 63
Sort By:
Cancers|December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical OutcomesLisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
American Journal of Clinical Pathology|January 13, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Carol Colasacco, et al.
Archives of Pathology & Laboratory Medicine|November 15, 2016
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
Nature Communications|July 22, 2024
Protective alleles and precision healthcare in crewed spaceflightLindsay A Rutter, Matthew J MacKay, Henry Cope, et al.
Nature Communications|June 11, 2024
Astronaut omics and the impact of space on the human body at scaleLindsay A Rutter, Henry Cope, Matthew J MacKay, et al.
Gynecologic Oncology|May 18, 2017
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiativeR J Edmondson, E J Crosbie, M Nickkho-Amiry, et al.
Plastic and Reconstructive Surgery. Global Open|April 10, 2023
A Consensus Approach for Targeted Muscle Reinnervation in AmputeesKyle R Eberlin, David A Brown, R Glenn Gaston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
Pageof 63

Showing results (571-580 of 630) with videos related to

Sort By:
Pageof 63
Cancers|December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical OutcomesLisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
American Journal of Clinical Pathology|January 13, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Carol Colasacco, et al.
Archives of Pathology & Laboratory Medicine|November 15, 2016
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
Nature Communications|July 22, 2024
Protective alleles and precision healthcare in crewed spaceflightLindsay A Rutter, Matthew J MacKay, Henry Cope, et al.
Nature Communications|June 11, 2024
Astronaut omics and the impact of space on the human body at scaleLindsay A Rutter, Henry Cope, Matthew J MacKay, et al.
Gynecologic Oncology|May 18, 2017
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiativeR J Edmondson, E J Crosbie, M Nickkho-Amiry, et al.
Plastic and Reconstructive Surgery. Global Open|April 10, 2023
A Consensus Approach for Targeted Muscle Reinnervation in AmputeesKyle R Eberlin, David A Brown, R Glenn Gaston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
Pageof 63